HER2-positive Metastatic Breast Cancer trials recruiting in District of Columbia

Fewer than 3 recruiting trials found.

All HER2-positive Metastatic Breast Cancer trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
  NCT06551116 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · District of Columbia: Washington D.C.